About this episode
Bloomberg Intelligence Senior Pharmaceutical Analyst Sam Fazeli covers the news that Merck will buy Prometheus Biosciences for about $10.8 billion to bolster its research pipeline and strengthen its portfolio of autoimmune drugs. Irving Fain, CEO of Bowery Farming, discusses disruption in the vertical farming space. Honeycomb CEO Christine Yen talks about new funding for the observability cloud platform. And We Drive to the Close with Doug Ciocca, CEO at Kavar Capital. Hosts: Carol Massar and Madison Mills. Producer: Paul Brennan. See omnystudio.com/listener for privacy information.
Comments
Rate this episode
Episode Details
- Author
- Bloomberg
- Show Type
- full
- Audio Format
- audio/mpeg